Incidence of secondary cancers. (A) Incidence of all secondary cancers as a function of treatment group. (B) Breakdown of the incidence of secondary MDS/AML (sMDS/AML; top panel) and second solid cancers (bottom panel). The solid line indicates the HDT group, the dashed line, the CHVP group.